Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells.
Molecules that inhibit the formation of an abnormal isoform of prion protein (PrP(Sc)) in prion-infected cells are candidate therapeutic agents for prion diseases. Understanding how these molecules inhibit PrP(Sc) formation provides logical basis for proper evaluation of their therapeutic potential....
Guardado en:
Autores principales: | Takeshi Yamasaki, Akio Suzuki, Rie Hasebe, Motohiro Horiuchi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d2059fa7fd464cee954a89f3fbabbb44 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers.
por: Mourad Tayebi, et al.
Publicado: (2011) -
The native state of prion protein (PrP) directly inhibits formation of PrP-amyloid fibrils in vitro
por: Ryo P. Honda, et al.
Publicado: (2017) -
Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain.
por: Sukhvir Paul Mahal, et al.
Publicado: (2012) -
Ethanolamine Is a New Anti-Prion Compound
por: Keiji Uchiyama, et al.
Publicado: (2021) -
Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles.
por: Vincenzo Mattei, et al.
Publicado: (2009)